Your browser doesn't support javascript.
loading
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
Hefazi, Mehrdad; Litzow, Mark; Hogan, William; Gastineau, Dennis; Jacob, Eapen; Damlaj, Moussab; Hashmi, Shahrukh; Al-Kali, Aref; Patnaik, Mrinal M.
Afiliação
  • Hefazi M; Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Litzow M; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Hogan W; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Gastineau D; Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota.
  • Jacob E; Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota.
  • Damlaj M; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Hashmi S; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Al-Kali A; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Patnaik MM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Transfusion ; 56(2): 518-27, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26446051

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article